City Hill Ventures
Contact Us  
Home About Us Team News
 
   
 

News and Events

Ignyta Completes Merger and Announces License Agreement for the Development of Two Leading Tyrosine Kinase Inhibitors

11.1.13 article

 
 
 
   
 
© 2010 City Hill Ventures, LLC Home    About Us    Team    Portfolio    News    Contact Us
 
Learn More